摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-ethyl-isovaleramide | 100868-92-6

中文名称
——
中文别名
——
英文名称
N-ethyl-isovaleramide
英文别名
N-Aethyl-isovaleramid;Isovaleriansaeure-aethylamid;Isovalerylaethylamin;N-ethyl isovaleramide;N-ethyl-3-methylbutanamide
<i>N</i>-ethyl-isovaleramide化学式
CAS
100868-92-6
化学式
C7H15NO
mdl
MFCD01351009
分子量
129.202
InChiKey
BOQSOBHPGBKUJL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    35-37 °C
  • 沸点:
    121 °C
  • 密度:
    0.859±0.06 g/cm3(Predicted)
  • 保留指数:
    1103

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.857
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    乙胺异戊酰氯乙醚 、 alkali hydroxide 作用下, 生成 N-ethyl-isovaleramide
    参考文献:
    名称:
    Einhorn; Hamburger, Justus Liebigs Annalen der Chemie, 1908, vol. 361, p. 126
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
    申请人:Tachdjian Catherine
    公开号:US20050084506A1
    公开(公告)日:2005-04-21
    The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.
    本发明涉及发现,某些非天然存在的非肽酰胺化合物和酰胺衍生物,如草酰胺、丙烯酰胺,可用作风味或口味调节剂,例如风味或调味剂和风味或口味增强剂,更具体地说,是用于食品、饮料和其他可食用或口服药品或组合物的风味或口味调节剂,包括鲜味(味精的“鲜味”)或甜味调节剂,鲜味或甜味调味剂以及鲜味或甜味增强剂。
  • THIAZOLYL-DIHYDRO-QUINAZOLINE
    申请人:Brandl Trixi
    公开号:US20070244104A1
    公开(公告)日:2007-10-18
    Disclosed are thiazolyl-dihydro-quinazolines of general formula (I) wherein the groups R 1 to R 4 have the meanings given in the claims and specification, the isomers thereof, and processes for preparing these compounds and their use as pharmaceutical compositions.
    揭示了一般式(I)的噻唑基-二氢喹唑啉化合物,其中基团R1至R4具有权利要求和说明书中给定的含义,其异构体,以及制备这些化合物的过程以及它们作为药物组成物的用途。
  • Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections
    申请人:Delorme Daniel
    公开号:US20080287396A1
    公开(公告)日:2008-11-20
    The present invention relates to phosphonated fluoroquinolones, antibacterial analogs thereof, and methods of using such compounds. These compounds are useful as antibiotics for prevention and/or the treatment of bone and joint infections, especially for the prevention and/or treatment of osteomyelitis.
    本发明涉及磷酸喹诺酮及其抗菌类似物,以及使用这些化合物的方法。这些化合物可用作抗生素,用于预防和/或治疗骨骼和关节感染,特别是用于预防和/或治疗骨髓炎。
  • PROCESS FOR ALKENYLATING CARBOXAMIDES
    申请人:Staffel Wolfgang
    公开号:US20090131657A1
    公开(公告)日:2009-05-21
    The present invention relates to a process for preparing N-(1-alkenyl)carboxamides of the formula I, which comprises reacting a carboxamide of the formula II with an alkyne of the formula III in the presence of a catalyst selected from among carbonyl complexes, halides and oxides of rhenium, manganese, tungsten, molybdenum, chromium and iron.
    本发明涉及一种制备式I的N-(1-烯基)羧酰胺的方法,包括在选择自的羰基配合物、卤化物和氧化物之一作为催化剂的情况下,将式II的羧酰胺与式III的炔烃反应。
  • GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS WITH IMPROVED SOLUBILITY
    申请人:Rafai Far Adel
    公开号:US20120149632A1
    公开(公告)日:2012-06-14
    The invention relates to derivatives of glycopeptide and lipoglycopeptide antibiotics possessing an altered ionization state with respect to the parent glycopeptide or lipoglycopeptide antibiotic, and having the ability to be regenerated as the parent glycopeptide or lipoglycopeptide antibiotic under physiological conditions. These compounds are useful as antibiotics for the prevention and/or the treatment of bacterial infections.
    这项发明涉及具有与母体糖肽或脂质糖肽抗生素相比具有改变的电离状态的糖肽和脂质糖肽抗生素衍生物,并且具有在生理条件下能够再生为母体糖肽或脂质糖肽抗生素的能力。这些化合物可用作预防和/或治疗细菌感染的抗生素。
查看更多